< Back to program committee

Simon de Lusignan

Role: Senior Programme Committee
Affiliation: The Royal College Of General Practitioners, UK

Prof Simon de Lusignan is a senior academic GP and Professor of Primary Care and Clinical Informatics; Chair in Health Care Management; and Head of Department of Department of Clinical and Experimental Medicine at University of Surrey – a  department that spans from surveillance, diabetes and cardiology; through a cancer research institute, to Medicines and Healthcare products Regulatory Agency (MHRA) approved clinical research facility and a newly approved Clinical Trials Unit (CTU).  Simon also leads a Surrey Health Partners, Primary Care Clinical Academic Group.

His roles include the Directorship of the Royal College of General Practice (RCGP) Research and Surveillance Centre (RSC); England’s primary care flu and infectious disease surveillance system; and leading a Lilly supported European RWE centre conducting research into type 2 diabetes. He is looking for opportunities in translational medicine linking “omics” data to phenotype data, as held in computerised medical records.

He has published more than 200 peer reviewed papers and articles, and has recently completed a large cluster randomised trial (QICKD trial – Kidney Int. 2013;84(3):609-20;Heart 2014 Dec;100(23):1837-43); conducted evaluations based on linked hospital, clinic and practice data (Behav Res Ther. 2013;51(7):377-85); and also the world’s largest series of consultation videos (J Am Med Inform Assoc. 2013 Jun;20(e1):e67-75).

His research focuses on how routinely collected data and other RWE can be used for quality improvement, improving health outcomes, and how IT is best used at the point of care.  He is  increasingly exploring how to work with linked datasets and exploring the interaction between factors such as physical and mental health, acute infection and chronic disease.  His quality improvement work has been in: cardiovascular disease, chronic kidney disease, diabetes, mental health, and vaccine preventable disease.  He has introduced agile methods, used in the software industry, into to his research group.

His role as the Director of the RCGP RSC includes producing weekly reports on disease prevalence, and partnership in an extensive range of research with Public Health England; and leadership of a work packages in a range of European research projects looking at vaccine preventable disease, uptake, benefits and risks.

Simon has been a partner in his practice for nearly 30 years and has been active in the local health community.

 

Supported by:

Partners: